16- and 17-year-olds are now eligible for a Pfizer/BioNTech Covid-19 vaccine booster
The US Food and Drug Administration on Thursday authorized the Pfizer/BioNTech Covid-19 vaccine for use as a booster in people ages 16 and 17, and the US Centers for Disease Contro…
